Clinical Trial Update: Research on the Individualized Treatment Strategy for Extremely Preterm Infants With hsPDA Based on Biomarkers and Targeted Delivery Systems

View source ↗

Summary

This clinical trial update describes a research study at Peking University Third Hospital investigating an individualized treatment strategy for hemodynamically…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Snippet

Sponsor: Peking University Third Hospital | Conditions: Hemodynamically Significant Patent Ductus Arteriosus | Status: NOT_YET_RECRUITING